DHG Pharmaceutical JSC - Asset Resilience Ratio

Latest as of December 2025: 39.18%

DHG Pharmaceutical JSC (DHG) has an Asset Resilience Ratio of 39.18% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₫2.02 Trillion

≈ $76.90 Million USD Cash + Short-term Investments

Total Assets

₫5.17 Trillion

≈ $196.27 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how DHG Pharmaceutical JSC's Asset Resilience Ratio has changed over time. Check DHG PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down DHG Pharmaceutical JSC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of DHG Pharmaceutical JSC.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₫0.00	0%
Short-term Investments	₫2.02 Trillion	39.18%
Total Liquid Assets	₫2.02 Trillion	39.18%

Asset Resilience Insights

Very High Liquidity: DHG Pharmaceutical JSC maintains exceptional liquid asset reserves at 39.18% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

DHG Pharmaceutical JSC Industry Peers by Asset Resilience Ratio

Compare DHG Pharmaceutical JSC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Alkem Laboratories Limited NSE:ALKEM	Drug Manufacturers - Specialty & Generic	31.91%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Alkermes plc F:8AK	Drug Manufacturers - Specialty & Generic	3.76%
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	Drug Manufacturers - Specialty & Generic	4.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%

Annual Asset Resilience Ratio for DHG Pharmaceutical JSC (2019–2025)

The table below shows the annual Asset Resilience Ratio data for DHG Pharmaceutical JSC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	39.18%	₫2.02 Trillion ≈ $76.90 Million	₫5.17 Trillion ≈ $196.27 Million	-6.88pp
2024-12-31	46.06%	₫2.75 Trillion ≈ $104.29 Million	₫5.96 Trillion ≈ $226.41 Million	+9.57pp
2023-12-31	36.49%	₫2.23 Trillion ≈ $84.73 Million	₫6.11 Trillion ≈ $232.16 Million	-9.07pp
2022-12-31	45.57%	₫2.35 Trillion ≈ $89.48 Million	₫5.17 Trillion ≈ $196.36 Million	-0.13pp
2021-12-31	45.69%	₫2.11 Trillion ≈ $80.17 Million	₫4.62 Trillion ≈ $175.44 Million	-0.94pp
2020-12-31	46.63%	₫2.07 Trillion ≈ $78.80 Million	₫4.45 Trillion ≈ $168.98 Million	+4.00pp
2019-12-31	42.64%	₫1.77 Trillion ≈ $67.17 Million	₫4.15 Trillion ≈ $157.55 Million	--

pp = percentage points

About DHG Pharmaceutical JSC

VN:DHG Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$470.92 Million

₫12.39 Trillion VND

Market Cap Rank

#12532 Global

#57 in Vietnam

Share Price

₫94800.00

Change (1 day)

+1.39%

52-Week Range

₫90200.00 - ₫108100.00

All Time High

₫130801.51